PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study reveals new therapeutic target for C. difficile infection

Study reveals new therapeutic target for C. difficile infection
2021-06-18
(Press-News.org) Irvine, CA - June 18, 2021 - A new study paves the way for the development of next generation therapeutics for the prevention and treatment of Clostridioides difficile infection (CDI), the most frequent cause of healthcare-acquired gastrointestinal infections and death in developed countries.

Published today in Nature Communications, the study reveals the first 3D structure of the Clostridioides difficile toxin B (TcdB) in complex with chondroitin sulfate proteoglycan 4 (CSPG4), a human receptor. The study was co-led by senior author Rongsheng Jin, PhD, a professor in the Department of Physiology & Biophysics at the University of California, Irvine, School of Medicine, and Min Dong, PhD, an associate professor at Harvard Medical School.

"TcdB is one of two homologous C. difficile exotoxins, which are major virulence factors responsible for the spread of C. difficile infections," explained Jin. "TcdB alone is capable of causing the full-spectrum of diseases associated with CDI in humans."

Previous studies had identified CSPG4 as a potential receptor for TcdB, however the pathophysiological relevance and molecular details were unknown. Results from this new study reveal a unique binding site involving TcdB and CSPG4, and also show that CSPG4-binding residues are highly conserved across most TcdB variants known to date.

CDI has become the most common cause of antibiotic-associated diarrhea and gastroenteritis-associated death in developed countries, accounting for approximately 223,900 infections, 12,800 deaths, and $1 billion in healthcare costs in the United States in 2017. It is classified as one of the top five "urgent threats" by CDC. There is also growing global concern surrounding the emergence of rapidly spreading hypervirulent C. difficile strains, reminiscent of the current COVID pandemic.

"What these new findings tell us is that a rationally designed CSPG4-mimicking decoy could neutralize major TcdB variants, providing a unique therapeutic avenue for combating some of the hypervirulent C. difficile strains," said Jin. In contrast, researchers also revealed that the therapeutic mechanism for bezlotoxumab, the only FDA approved anti-TcdB antibody, is sensitive to escaping mutations in some bacterial strains.

The current standard of care for CDI involves treatments using broad spectrum antibiotics, which often lead to frequent disease recurrence. While bezlotoxumab could reduce the recurrence rate of CDI in some patients, results from this and some earlier studies indicate it has weaker potency against some TcdB variants.

"We have designed a CSPG4-mimicking decoy based on the 3D structure we observed, which could neutralize major TcdB variants and is superior to bezlotoxumab on a major TcdB variant from a hypervirulent strain (TcdB2) in our studies. As a highly conserved cellular receptor of TcdB, a CSPG4 decoy molecule would be difficult for TcdB to escape, since any mutations that disrupt toxin binding to the decoy would also disrupt binding to its native receptors," said Jin.

The team of researchers has also developed a family of recombinant protein therapeutics based on these new findings, as well as on an earlier discovery on how TcdB recognizes another human receptor Frizzled (FZD).

"We are now examining the therapeutic features of these novel antitoxin molecules, and we believe they could provide broad-spectrum protection and neutralization against most known TcdB variants, thus improving existing antibody therapeutics for CDI," said Jin, whose team has filed a patent on these neutralizing molecules.

INFORMATION:

This work was supported by part by the National Institutes of Health, Niedersächsisches Vorab, Deutsche Forschungsgemeinschaft, and the Burroughs Wellcome Fund.

About the UCI School of Medicine Each year, the UCI School of Medicine educates more than 400 medical students, and nearly 150 doctoral and master's students. More than 700 residents and fellows are trained at UCI Medical Center and affiliated institutions. The School of Medicine offers an MD; a dual MD/PhD medical scientist training program; and PhDs and master's degrees in anatomy and neurobiology, biomedical sciences, genetic counseling, epidemiology, environmental health sciences, pathology, pharmacology, physiology and biophysics, and translational sciences. Medical students also may pursue an MD/MBA, an MD/master's in public health, or an MD/master's degree through one of three mission-based programs: the Health Education to Advance Leaders in Integrative Medicine (HEAL-IM), the Leadership Education to Advance Diversity-African, Black and Caribbean (LEAD-ABC), and the Program in Medical Education for the Latino Community (PRIME-LC). The UCI School of Medicine is accredited by the Liaison Committee on Medical Accreditation and ranks among the top 50 nationwide for research. For more information, visit som.uci.edu.


[Attachments] See images for this press release:
Study reveals new therapeutic target for C. difficile infection

ELSE PRESS RELEASES FROM THIS DATE:

New artificial heart shows promising results in 'auto-mode' -- initial clinical experience reported in ASAIO Journal

2021-06-18
June 18, 2021 - An experimental artificial heart includes an autoregulation control mechanism, or Auto-Mode, that can adjust to the changing needs of patients treated for end-stage heart failure. Outcomes in the first series of patients managed with the new heart replacement pump in Auto-Mode are presented in the ASAIO Journal, official journal of the American Society for Artificial Internal Organs. The journal is published in the Lippincott portfolio by Wolters Kluwer. The study reports on the response to "pressure sensor-based autoregulation of blood flow" in ten patients for up to two years after implantation of the Carmat Total Artificial ...

Picky neurons

Picky neurons
2021-06-18
The visual thalamus is classically known to relay visual stimuli coming from the retina to the cerebral cortex. Researchers from the Max Planck Institute of Neurobiology now show that although neurons in the mouse visual thalamus connect to both eyes, they establish strong functional connections only with one retina. These results settle partly contradictory results of earlier studies and demonstrate how important it can be to complement structural data with functional analyses. We have two eyes, but perceive the tree in front of us only once. Our brain therefore has the complicated task of combining the information of both eyes in a meaningful way. To do so, visual stimuli first travel from the retina via so-called ganglion cells to the visual thalamus. There, the information does end up ...

Does cannabis affect brain development in young people with ADHD? Too soon to tell, reports Harvard Review of Psychiatry

2021-06-18
June 18, 2021 - At least so far, the currently limited research base does not establish that cannabis has additional adverse effects on brain development or functioning in adolescents or young adults with attention-deficit/hyperactivity disorder (ADHD), concludes a review in the July/August issue of Harvard Review of Psychiatry. The journal is published in the Lippincott portfolio by Wolters Kluwer. While ADHD is clinically defined to have impairments in cognitive functioning, cannabis use by itself is also associated with cognitive impairments: "[T]he evidence to date does not clearly support either an addictive effect or an interaction - whether protective ...

Researchers find optimal way to pay off student loans

2021-06-18
After graduating or leaving college, many students face a difficult choice: Try to pay off their student loans as fast as possible to save on interest, or enroll in an income-based repayment plan, which offers affordable payments based on their income and forgives any balance remaining after 20 or 25 years. There are pros and cons to each option, and trying to discern the better path can be daunting. That's why University of Colorado Boulder's Yu-Jui Huang and Saeed Khalili, a former graduate student in financial mathematics, along with Dublin City University's Paolo Guasoni, decided to throw a little mathematical ...

Use rewards effectively to boost creativity

2021-06-18
HOUSTON - (June 18, 2021) - To boost employees' creativity, managers should consider offering a set of rewards for them to choose from, according to a new study by management experts at Rice University, Tulane University, the University of North Carolina at Greensboro and National Taiwan Normal University. The study, co-authored by Jing Zhou, the Mary Gibbs Jones Professor of Management and Psychology at Rice's Jones Graduate School of Business, is the first to systematically examine the effects of reward choice in a field experiment, which was conducted in the context of an organizationwide suggestion ...

Researchers find losartan is not effective in reducing hospitalization from mild COVID-19

2021-06-18
MINNEAPOLIS/ST. PAUL (06/18/2021) -- University of Minnesota Medical School researchers determined that the common blood pressure medication, losartan, is not effective in reducing hospitalization for mildly-ill COVID-19 outpatients. In the multicenter, randomized, double-blinded clinical trial, non-hospitalized patients recently diagnosed with COVID-19 were given either losartan or a placebo and monitored for 15 days. The study's results, which were published in END ...

Scientists detect signatures of life remotely

Scientists detect signatures of life remotely
2021-06-18
Left hands and right hands are almost perfect mirror images of each other. But whatever way they are twisted and turned, they cannot be superimposed onto each other. This is why the left glove simply won't fit the right hand as well as it fits the left. In science, this property is referred to as chirality. Just like hands are chiral, molecules can be chiral, too. In fact, most molecules in the cells of living organisms, such as DNA, are chiral. Unlike hands, however, that usually come in pairs of left and right, the molecules of life almost exclusively occur in either their "left-handed" or their "right-handed" version. They are homochiral, as researchers say. Why that is, is still not clear. But ...

Team describes science-based hiccups intervention

Team describes science-based hiccups intervention
2021-06-18
SAN ANTONIO (June 18, 2021) -- Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and colleagues worldwide describe a new science-based intervention for hiccups in a research letter published June 18 in the journal JAMA Network Open. In the publication, the scientists coined a new term for the intervention: the "forced inspiratory suction and swallow tool," or FISST. The team also reported the results of a survey of 249 users who were asked whether it is superior to hiccup home remedies such as breathing into ...

Princeton-led team discovers unexpected quantum behavior in kagome lattice

2021-06-18
An international team led by researchers at Princeton University has uncovered a new pattern of ordering of electric charge in a novel superconducting material. The researchers discovered the new type of ordering in a material containing atoms arranged in a peculiar structure known as a kagome lattice. While researchers already understand how the electron's spin can produce magnetism, these new results provide insights into the fundamental understanding of another type of quantum order, namely, orbital magnetism, which addresses whether the charge can spontaneously flow in a loop and produce magnetism dominated by extended orbital motion of electrons in a lattice of atoms. Such orbital currents can produce unusual quantum ...

Overcoming a newly recognized form of resistance to modern prostate cancer drugs

Overcoming a newly recognized form of resistance to modern prostate cancer drugs
2021-06-18
Cancer cells have an uncanny ability to evolve and adapt to overcome the treatments used against them. While patient survival has been extended by modern drugs that block the production or action of male hormones that fuel prostate cancer -- androgen receptor inhibitors such as enzalutamide, apalutamide, darolutamide, and abiraterone -- eventually these drugs stop working. At that point, a patient's disease is considered incurable, or what doctors call metastatic, castration-resistant prostate cancer. In a new study, a team of researchers led by Joshi Alumkal, M.D., who ...

LAST 30 PRESS RELEASES:

New study identifies growth hormone receptor as possible target to improve lung cancer treatment

Routine helps children adjust to school, but harsh parenting may undo benefits

IEEE honors Pitt’s Fang Peng with medal in power engineering

SwRI and the NPSS Consortium release new version of NPSS® software with improved functionality

Study identifies molecular cause of taste loss after COVID

Accounting for soil saturation enhances atmospheric river flood warnings

The research that got sick veterans treatment

Study finds that on-demand wage access boosts savings and financial engagement for low-wage workers

Antarctica has lost 10 times the size of Greater Los Angeles in ice over 30 years

Scared of spiders? The real horror story is a world without them

New study moves nanomedicine one step closer to better and safer drug delivery

Illinois team tests the costs, benefits of agrivoltaics across the Midwest

Highly stable self-rectifying memristor arrays: Enabling reliable neuromorphic computing via multi-state regulation

Composite superionic electrolytes for pressure-less solid-state batteries achieved by continuously perpendicularly aligned 2D pathways

Exploring why some people may prefer alcohol over other rewards

How expectations about artificial sweeteners may affect their taste

Ultrasound AI receives FDA De Novo clearance for delivery date AI technology

Amino acid residue-driven nanoparticle targeting of protein cavities beyond size complementarity

New AI algorithm enables scientific monitoring of "blue tears"

Insufficient sleep among US adolescents across behavioral risk groups

Long COVID and recovery among US adults

Trends in poverty and birth outcomes in the US

Heterogeneity of treatment effects of GLP-1 RAs for weight loss in adults

Within-person association between daily screen use and sleep in youth

Low-dose lithium for mild cognitive impairment

Catheter ablation and oral anticoagulation for secondary stroke prevention in atrial fibrillation

A new theory of brain development

Pilot clinical trial suggests low dose lithium may slow verbal memory decline

Bioprinting muscle that knows how to align its cells just as in the human body

A hair-thin fiber can read the chemistry of a single drop of body fluid

[Press-News.org] Study reveals new therapeutic target for C. difficile infection